RETA + ELORA

RT3 + ELORA  |  25MG

ADVANCED QUAD-PATHWAY METABOLIC RESEARCH BLEND

Explore the next frontier of metabolic science.

Product Overview

At Origin.1, we believe the future of metabolic research lies in understanding how the body’s natural signaling systems work together. RT3 + ELORA brings two investigational peptides into one lyophilized research formulation, designed for scientific exploration of appetite regulation, energy metabolism, nutrient signaling, and metabolic adaptation.

The 25MG blend contains 20MG Retatrutide (RT3) and 5MG Eloralintide (ELORA). Retatrutide targets GLP-1, GIP, and glucagon receptors, while Eloralintide targets amylin signaling—four complementary receptor pathways of interest in metabolic science.

The Science Behind the Blend

Retatrutide (RT3) — 20MG

Retatrutide is an investigational triple-receptor agonist with activity at:

• GLP-1 receptors — involved in satiety signaling, gastric function, and glucose-dependent insulin secretion.

• GIP receptors — involved in nutrient-responsive insulin signaling and metabolic regulation.

• Glucagon receptors — involved in hepatic energy metabolism, glucose production, and energy expenditure.

These pathways are being investigated for their influence on body-weight regulation, glucose homeostasis, and cardiometabolic function.

Eloralintide (ELORA) — 5MG

Eloralintide is an investigational selective amylin receptor agonist, with a particular focus on AMY1 signaling. Amylin is naturally co-secreted with insulin following nutrient intake and participates in central satiety and meal-related signaling.

Its research areas include appetite and fullness signaling, food intake, energy balance, and complementary activity with incretin-based pathways.

Four Pathways. One Research Formulation.

The combination brings together three incretin/glucagon-related signaling pathways and a distinct amylin-mediated pathway. This provides a research framework for investigating interactions between hunger, satiety, glucose regulation, and energy expenditure. The combination itself has not been clinically established as safe or effective, and additive or synergistic effects have not been demonstrated.

Key Research Areas

Advanced appetite signaling: Interactions among incretin, glucagon, and amylin pathways involved in hunger, fullness, and food intake.

Metabolic regulation: Hormone receptor involvement in energy balance, nutrient utilization, and metabolic adaptation.

Glucose homeostasis: Complementary signaling roles in metabolic responses to nutrients.

Body composition research: Relationships among body-weight regulation and changes in fat and lean tissue.

Multi-pathway peptide research: Comparative investigation of receptor mechanisms and their interactions.

The Origin.1 Philosophy

Restore What Was Always There.

Human metabolism is an intricate network of biological communication. RT3 + ELORA represents an investigational approach to studying multiple metabolic signaling systems together rather than examining each one in isolation. At Origin.1, our mission is to support scientific curiosity and a deeper understanding of human biology.

ORIGIN.1  —  BUILD. ADAPT. BECOME.

Product Specifications

Research Use Disclaimer

NOT FOR HUMAN CONSUMPTION | RESEARCH USE ONLY. This formulation is intended exclusively for laboratory research. Neither individual compound nor the RT3 + ELORA combination is an approved treatment. Safety, effectiveness, and optimal use of this specific blend have not been established in clinical trials. Product-specific purity claims require supporting batch test results.